ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

URGN UroGen Pharma Ltd

14.30
0.04 (0.28%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
UroGen Pharma Ltd URGN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.04 0.28% 14.30 08:22:00
始値 安値 高値 終値 前日終値
14.50 14.14 14.70 14.30 14.26
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0504:20BWUroGen Announces Results from ATLAS Showing Robust UGN-102..
2024/5/0500:50BWNew Real-World Study on Retrograde Instillation of JELMYTO®..
2024/5/0321:00BWUroGen Pharma to Report 2024 First Quarter Financial Results..
2024/4/1801:02BWUroGen Announces New Data Presentations at the American..
2024/4/1521:00BWUroGen Announces FDA Acceptance of Investigational New Drug..
2024/4/0321:00BWUroGen Pharma Files Patent Infringement Action Against Teva..
2024/3/1421:00BWUroGen Pharma Delivers Double Digit JELMYTO® Growth and..
2024/3/0822:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
2024/3/0422:00BWUroGen Pharma to Report Fourth Quarter and Full-Year 2023..
2024/3/0421:00EDGAR2Form 8-K - Current report
2024/3/0121:00EDGAR2Form 8-K - Current report
2024/2/2622:00BWUroGen Pharma to Present at TD Cowen 44th Annual Health Care..
2024/2/1307:47EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
2024/2/0806:15EDGAR2Form 8-K - Current report
2024/2/0309:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0309:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0309:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0309:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0200:13EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0123:53EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0122:00BWUroGen Pharma to Participate at Upcoming Investor..
2024/1/2422:00BWUroGen Initiates Submission of a Rolling NDA to the FDA for..
2024/1/1806:16EDGAR2Form 8-K - Current report
2024/1/1722:00BWUroGen Secures Exclusive License from medac GmbH to Develop..
2024/1/1122:00BWUroGen Pharma to Participate in the B. Riley Healthcare..
2024/1/0222:04EDGAR2Form 8-K - Current report
2023/12/0906:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
2023/11/1506:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/11/1422:00BWUroGen Pharma Reports Third Quarter 2023 Financial Results
2023/11/1322:00BWUroGen will Present Scientific Advances in Bladder Cancer at..
2023/11/0722:00BWUroGen Pharma to Report Third Quarter 2023 Financial Results..
2023/10/0321:00BWFollowing Pre-NDA Meeting with the FDA, UroGen Announces..
2023/9/1205:15EDGAR2Form 8-K - Current report
2023/9/1120:00GLOBEEledon Pharmaceuticals Appoints Industry Veteran James..
2023/9/0905:16EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/9/0904:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0904:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0904:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0904:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0904:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0904:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0904:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0821:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
2023/9/0605:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3121:00BWUroGen Pharma to Present at Upcoming Investor Conferences
2023/8/1021:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1021:01EDGAR2Form 8-K - Current report
2023/8/1021:00BWUroGen Pharma Reports Record JELMYTO Quarterly Sales and..
2023/8/0821:00BWThe Journal of Urology Publishes Peer-Reviewed Article..
2023/8/0421:56EDGAR2Form SC 13D - General statement of acquisition of beneficial..

最近閲覧した銘柄

Delayed Upgrade Clock